Beijing Minhai Biotechnology Co., Ltd

This trial is testing a new tetanus vaccine in healthy adults aged 18 to 43. The goal is to see if the vaccine is safe and triggers a strong immune response, measured by antibody levels one month after vaccination. Participants will receive either the new vaccine or a control vac…

This completed Phase 3 trial tested a new Sabin strain inactivated polio vaccine (sIPV) in 1200 healthy infants aged 2 months. The study compared the new vaccine to a standard polio vaccine to see if it was safe and triggered a strong immune response. The goal is to offer a more …